QTc interval prolongation associated with intravenous methadone. - Wikidata - awgldk - TriplyDB

QTc interval prolongation associated with intravenous methadone.

QTc interval prolongation associated with intravenous methadone.

http://www.wikidata.org/entity/Q34267653

about

QTc interval screening for cardiac risk in methadone treatment of opioid dependence ECG screening for preventing long QTc-related cardiac morbidity/mortality in methadone treated opioid addicts A systematic review of the cardiotoxicity of methadone Methadone treatment of chronic non-malignant pain and opioid dependence--a long-term follow-up Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen.Drink, drugs, and the QT interval.QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France.Gender issues in the pharmacotherapy of opioid-addicted women: buprenorphine.QT interval screening in methadone maintenance treatment: report of a SAMHSA expert panel.Retrospective analysis of low-dose methadone and QTc prolongation in chronic pain patients.The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study.A modeling and simulation approach to characterize methadone QT prolongation using pooled data from five clinical trials in MMT patients.An analysis of the root causes for opioid-related overdose deaths in the United States.Toward a systematic approach to opioid rotation.Adverse events associated with sedatives, analgesics, and other drugs that provide patient comfort in the intensive care unit.Torsades de pointes associated with methadone and voriconazole.Torsade de pointes caused by polypharmacy and substance abuse in a patient with human immunodeficiency virus.Methodology for the Randomised Injecting Opioid Treatment Trial (RIOTT): evaluating injectable methadone and injectable heroin treatment versus optimised oral methadone treatment in the UK.Methadone induced torsades de pointes and ventricular fibrillation: A case review.Levo-alpha-acetylmethadol (LAAM) induced QTc-prolongation - results from a controlled clinical trial Methadone for cancer pain: what have we learned from clinical studies?The successful use of parenteral methadone in a patient with a prolonged QTc interval.Case files of the Drexel University Medical Toxicology Fellowship: methadone-induced QTc prolongation The Impact of Opioids on Cardiac Electrophysiology.Methadone death, dosage and torsade de pointes: risk-benefit policy implications.Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology.Intravenous Methadone for Severe Cancer Pain: A Presentation of 10 Cases Methadone-Associated QTc Prolongation: A Case Report and Review of the Literature.Interindividual variability of methadone response: impact of genetic polymorphism.Oxycodone is associated with dose-dependent QTc prolongation in patients and low-affinity inhibiting of hERG activity in vitro Consensus guideline on parenteral methadone use in pain and palliative care.Methadone, QTc interval prolongation and torsade de pointes: Case reports offer the best understanding of this problem.Risk-factors for methadone-specific deaths in Scotland's methadone-prescription clients between 2009 and 2013 A community-based evaluation of sudden death associated with therapeutic levels of methadone.Methadone, QTc prolongation and torsades de pointes: Current concepts, management and a hidden twist in the tale?Methadone maintenance dosing guideline for opioid dependence, a literature review.Onsite QTc interval screening for patients in methadone maintenance treatment.Effect of methadone maintenance treatment on heroin craving, a literature review.Opioid side effects and their treatment in patients with chronic cancer and noncancer pain.QTc interval prolongation by d-propoxyphene: what about other analgesics?

P2860

Q24201880-39967D99-F549-420C-B7E9-2ECB3CF90975 Q24235379-99D5CEF9-97FC-475A-BD11-47FEA975D3DF Q26766513-1132AD95-5DEB-4FE3-9EE4-052B173F4D09 Q28257915-CC526260-3D9A-41A5-A5AA-58A94E320F21 Q33154871-FD60D2D4-3CF2-47BC-A761-C54FA3FE5C49 Q33158205-15004575-65A5-42CA-8B21-32D20CE36734 Q33687681-0BD6BFBC-AB23-4F02-B5EA-AA58DD57B960 Q33807411-68A2BEBA-1C58-46FA-B0E7-ED5769BA26EB Q33835424-E4534FC7-1823-4F55-83D5-3472878C5AA4 Q33878154-8CE285AE-4A97-4807-95A5-21A6D52A45A7 Q34129646-60B19A1F-5B13-4A68-8C73-6567DF4CE015 Q34179339-A0BFD62D-EBF0-4E12-A079-AC25F8B75C95 Q34192078-4964D21C-7DE3-41AC-845B-DB74A07213C4 Q34394425-601463AA-F46D-49C5-8867-3982BAC67A5E Q34419506-1A870560-3173-4A94-B1EE-364A69ADC426 Q34527805-5A27C8CB-9BCF-4786-86F9-BFE2863C2D7B Q34606790-12A89959-E551-485C-9035-502E2511C87C Q35094562-0AEF4E37-A9ED-41B4-8187-B45EF18650A8 Q35160624-6696AE2A-392A-4061-904F-390AFC624A86 Q35959993-57A8EA1A-DCEC-4E3E-81D4-6F62C73A8280 Q36135137-04C1F23B-B21C-46C7-AD08-3F5A942CD4DE Q36202929-C1EAD618-649E-4DB3-B3D1-C7D42205933E Q36548333-F1A8FECD-9435-48F1-AA7B-254106145A44 Q36728665-72C52C04-273D-4FB3-95BD-8A2142416F67 Q36764780-ADD8FB51-76A5-49E4-A378-35D0647B353B Q36811537-A959AAA0-1FB6-4DA4-AE3A-12751258472E Q36969714-3DAAA21A-8977-4FDD-A69F-6287D3ACDB76 Q37101714-5D4D1AC2-8A0E-4340-80A5-FCFB3B58C1AD Q37142009-113B4E5F-85FA-4446-A0B1-5EB389763E99 Q37161503-746FF81E-BCB9-4068-93A6-0F8D82F3B703 Q37172055-36B81240-7C73-4861-9F65-F8965EA17E09 Q37248049-0F613E7F-C70D-4FD3-9422-D667B8FA28E8 Q37304594-DF7E82F0-F27F-403E-957F-EFB618CD495B Q37326899-BDCF45D4-A2CE-4090-9A65-5CFCDF22EBC2 Q37636417-80A84CE9-0BE8-4C6D-A5FF-0FF5932ECF32 Q37730680-8F1468A2-0BE8-4334-8FC5-A2ED30CD2FFA Q37730683-2369C724-01F8-49F5-A0E4-9666A131E482 Q37827079-96D6413F-B587-4547-8130-6B85F06E859F Q37933355-65A6AC7E-7434-4EB5-9BE1-C8C3DDD3CEBF Q38008460-CF48FF9B-8E30-4B04-97B2-09E67765FAEB

P2860

QTc interval prolongation associated with intravenous methadone.

http://www.wikidata.org/entity/Q34267653

description

2003 nî lūn-bûn

@nan

2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

QTc interval prolongation associated with intravenous methadone.

@ast

QTc interval prolongation associated with intravenous methadone.

@en

QTc interval prolongation associated with intravenous methadone.

@nl

type

label

QTc interval prolongation associated with intravenous methadone.

@ast

QTc interval prolongation associated with intravenous methadone.

@en

QTc interval prolongation associated with intravenous methadone.

@nl

prefLabel

QTc interval prolongation associated with intravenous methadone.

@ast

QTc interval prolongation associated with intravenous methadone.

@en

QTc interval prolongation associated with intravenous methadone.

@nl

P1433

Q34267653-C39898A8-0067-412F-A164-C1E940930E9E

P1476

Q34267653-1210BCF5-00E0-4C30-89E7-4BFE9A3F63CD

P2093

Q34267653-11C59ACF-DEB9-412B-9F37-B15C81358038

Q34267653-414C6D61-CE8B-4B40-BF7F-336F793E2B8C

Q34267653-5882536E-B5B4-42D6-B73F-DEE38B5D28F0

Q34267653-5B68ED51-F3E0-45A1-BF1B-59E7FAC38DB3

Q34267653-7BF2B02E-2E57-4F71-8E1A-DCEDB551AE5E

Q34267653-912F31A4-574B-4F5F-9054-4972D2A9C98F

Q34267653-979A3DFC-B89F-4266-85D3-158B43CC3DFF

Q34267653-97C2AF70-F756-4E6A-9AE3-37266B3E4300

Q34267653-C2260675-9160-4488-9CC7-01393FA7C340

Q34267653-C7B49E86-5C72-4C09-A09C-5060D41D2849

P304

Q34267653-B2CE2851-6BE9-4648-8C33-F17A31850DE9

P31

Q34267653-4C1EA365-0491-4FE1-8DDE-94249ACE9A0F

P356

Q34267653-92FEC1EB-1EB3-4699-A49E-AF2B589FDECC

P407

Q34267653-FD110081-1C11-4492-A05B-7C5D2C0F6FF0

P433

Q34267653-EA387864-0806-4C78-A122-690CE60491DF

P478

Q34267653-04577E8E-6290-4975-AC59-C3B8C89F51C6

P50

Q34267653-C3FC6F02-9BFC-41B7-AACA-BB728F7F20C3

P577

Q34267653-9B132D22-FA4F-4896-A43F-1C623D749758

P5875

Q34267653-FF690652-4F6E-466E-BB61-0FA12450E09F

P698

Q34267653-017542ED-962E-4015-9B49-E0A60B351032

P356

S0304-3959(03)00205-7

P1433

P1476

QTc interval prolongation associated with intravenous methadone

@en

P2093

Alexander N Katchman

http://www.w3.org/2001/XMLSchema#string

Craig A Kornick

http://www.w3.org/2001/XMLSchema#string

Deborah L Keefe

http://www.w3.org/2001/XMLSchema#string

Glenn Schulman

http://www.w3.org/2001/XMLSchema#string

Howard T Thaler

http://www.w3.org/2001/XMLSchema#string

John C Pezzullo

http://www.w3.org/2001/XMLSchema#string

Juan Santiago-Palma

http://www.w3.org/2001/XMLSchema#string

Michael J Kilborn

http://www.w3.org/2001/XMLSchema#string

Paolo L Manfredi

http://www.w3.org/2001/XMLSchema#string

Richard Payne

http://www.w3.org/2001/XMLSchema#string

P304

499-506

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0304-3959(03)00205-7

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P50

Raymond L Woosley

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

9063994

http://www.w3.org/2001/XMLSchema#string

P698

14527710

http://www.w3.org/2001/XMLSchema#string